Informative Exhibition for Deprescribing Benzodiazepines
Impact of an Interactive and Informative Exhibition on Benzodiazepine Use on Deprescription.
Consorci Sanitari de l'Alt Penedès i Garraf
6,410 participants
Jun 13, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is: • Does an interactive and informative exhibition reduce the number of participants using benzodiazepines? Researchers will compare benzodiazepine consumption before and after the interactive and informative exhibition implementation at study center. Participants will receive an informative and interactive exhibition on the risks of chronic benzodiazepine use. A single informative session on the same topic will be conducted for health professionals.
Eligibility
Inclusion Criteria2
- Men and women between 18 and 99 years of age.
- Attended at the Baix-a-Mar Primary Care Center during the study period.
Exclusion Criteria3
- Severe mental health disease
- Displaced patients or those who do not have an assigned doctor at the center.
- Participation in another study involving an experimental intervention during the period of the present study that affects benzodiazepine prescription.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention consists of implementing an interactive exhibition on the risks of chronic benzodiazepine treatment in the waiting room of a primary care center. Additionally, the health professionals at the center will receive a single informative session on the same topic.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06467019